Skip to Main Content

Paper Details

Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy.
Clin Cancer Res
6
2021
IMiD, IRF4, Multiple Myeloma, Omacetaxine, c-MYC, chimeric antigen receptor, multiple, multiple myeloma, multiple myeloma cell, multiple myeloma cells, myeloma, myeloma cell lines, normal marrow cells, omacetaxine, patient, patients, primary, primary multiple myeloma, primary patient, primary patient multiple myeloma cells, relapsed/refractory
Author NameAffiliation
Brett M StevensUniversity of Colorado Anschutz Medical Campus
Clayton A SmithUniversity of Colorado Anschutz Medical Campus
Clayton A SmithUniversity of Colorado Cancer Center, University of Colorado Anschutz Medical Campus
Veronica Clavijo JordanUniversity of Colorado Anschutz Medical Campus
Veronica Clavijo JordanUniversity of Colorado Cancer Center, University of Colorado Anschutz Medical Campus
Veronica Clavijo JordanUniversity of Colorado Anschutz Medical Campus
Veronica Clavijo JordanUniversity of Colorado Cancer Center, University of Colorado Anschutz Medical Campus
  • 1 - 7

Datasets

Release 1.2